2care4 Generics ApS: Financial statements 2017
CVR: 36960566
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,519,397 and a net result of DKK -6,026,345. Equity in the 2017 report amounted to DKK 330,398. The solvency ratio was 2.7%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -1,519,397
- Profit/Loss
- DKK -6,026,345
- Equity
- DKK 330,398
- Total Assets
- DKK 12,384,105
- Employees
- 5
Keep an eye on 2care4 Generics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
2care4 Generics ApS has published its interim report for the period July 10, 2015 – December 31, 2016.
About 2care4 Generics ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.